UK Clinical Vaccine Network Conference 2022

Bringing together and showcasing the work of the UK clinical vaccine community, to facilitate co-operation and collaborate on future challenges.

Register now

It is with great excitement that we can announce this year’s Clinical Vaccine Network Conference will be held in person at the Royal College of Physicians, London.

Hosted on the 30th June, this event will cover a wide spectrum of issues in vaccine development, presentations on the latest research, and the future of vaccines.

Whilst this conference will be made available to join virtually we thoroughly recommend attending in person to not miss out on this excellent networking opportunity. There will be an array of UK healthcare professionals, and other relevant decision makers who have a specific interest in vaccine intervention in the patient pathway.

Please share the flyer for the event available here with your colleagues.

If you have any queries, or would like to enquire about sponsorship of this event, please contact: hayley@pagemedical.co.uk.

@CVN_UK

To view the recordings from the online UK Clinical Vaccine Network Conference held in 2020 please click here

Dr Angela Minassian

I am Chief Investigator and clinical lead on the blood-stage and transmission blocking malaria vaccine programmes headed by Prof Simon Draper and Prof Sumi Biswas. This programme of work includes testing of first-time-in-man vaccines against both Plasmodium falciparum and P. vivax malaria, incorporating controlled human malaria infection to test efficacy. I am currently running a first-time-in-man Phase I/IIa trial of the protein vaccine RH5.1/AS01B, which incorporates the PfRH5 antigen – the first reported target in the P. falciparum merozoite that is highly susceptible to broadly-neutralising vaccine-induced antibodies.

My main research interest is in human challenge models of infection, having completed a DPhil at the Jenner Institute in 2009 which involved development of a human challenge model against tuberculosis, using BCG as a surrogate. Prior to this I was lead investigator on several TB vaccine trials, including that of the first candidate prophylactic TB vaccine to have been administered to HIV-infected individuals.

I am a qualified Consultant in Infectious Diseases and Microbiology, having completed my specialist training at OUH NHS Trust in 2014, and spent a year working as a Consultant in Infectious Diseases at the Heart of England NHS Trust in Birmingham. I continue working there as an Honorary Consultant.

Top